First Citizens Financial Corp’s AstraZeneca AZN Stock Holding History

First Citizens Financial Corp’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,298	Closed	-$202K	–	122
2024 Q3	$202K	Hold	1,298	–	–	0.11%	119
2024 Q2	$202K	Buy	+1,298	New	+$195K	0.12%	112
2023 Q4	–	Sell	-1,538	Closed	-$208K	–	112
2023 Q3	$208K	Hold	1,538	–	–	0.15%	107
2023 Q2	$220K	Buy	+1,538	New	+$226K	0.15%	105
2022 Q4	$208K	Buy	+1,538	New	+$193K	0.18%	94
2022 Q3	–	Sell	-1,538	Closed	-$203K	–	94
2022 Q2	$203K	Hold	1,538	–	–	0.18%	95
2022 Q1	$204K	Buy	+1,538	New	+$184K	0.15%	101
2021 Q1	–	Sell	-2,563	Closed	-$256K	–	107
2020 Q4	$256K	Hold	2,563	–	–	0.22%	86
2020 Q3	$281K	Hold	2,563	–	–	0.28%	73
2020 Q2	$271K	Sell	2,563 -350	-12%	-$36.1K	0.28%	73
2020 Q1	$260K	Hold	2,913	–	–	0.34%	60
2019 Q4	$290K	Buy	+2,913	New	+$274K	0.29%	70

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

First Citizens Financial Corp's AZN Position: Q4 2024 in Review

First Citizens Financial Corp sold out of AstraZeneca (AZN) in Q4 2024, closing a stake of 1,298 shares — an estimated $202K sold.

First Citizens Financial Corp first reported a position in AZN in Q4 2019 and held it in 12 quarters. The position peaked at $290K in Q4 2019. 1,219 funds tracked by Wall St. Rank hold AZN as of Q4 2024.

First Citizens Financial Corp reported no remaining AstraZeneca position as of Q4 2024 after selling out during the quarter.
First Citizens Financial Corp sold 1,298 AstraZeneca shares in Q4 2024, an estimated $202K.
First Citizens Financial Corp first reported a position in AstraZeneca in Q4 2019 and held it in 12 quarters.
First Citizens Financial Corp's AstraZeneca position peaked at $290K in Q4 2019.
1,219 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2024.

Based on First Citizens Financial Corp's 13F filing for Q4 2024, filed 3 Jan 2025.